Works about CYCLIN-dependent kinase inhibitors
Results: 1176
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56279-x
- By:
- Publication type:
- Article
细胞周期蛋白依赖性激酶 7 抑制剂 THZ1 对脑胶质瘤干细胞干性的调控及机制.
- Published in:
- Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu, 2025, v. 29, n. 25, p. 5374, doi. 10.12307/2025.528
- By:
- Publication type:
- Article
A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 2, p. 360, doi. 10.3390/medicina61020360
- By:
- Publication type:
- Article
Adiponectin C1Q and Collagen Domain Containing rs266729, Cyclin-Dependent Kinase Inhibitor 2A and 2B rs10811661, and Signal Sequence Receptor Subunit 1 rs9505118 Polymorphisms and Their Association with Gestational Diabetes Mellitus: A Case-Control Study in a Romanian Population
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1654, doi. 10.3390/ijms26041654
- By:
- Publication type:
- Article
CDK4/6 inhibitors upregulate cIAP1/2, and Smac mimetic LCL161 enhances their antitumor effects in cholangiocarcinoma cells.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-90997-y
- By:
- Publication type:
- Article
Stroke neurobiobanking and genomic research in Africa: a narrative review.
- Published in:
- Egyptian Journal of Neurology, Psychiatry & Neurosurgery, 2025, v. 61, n. 1, p. 1, doi. 10.1186/s41983-025-00941-0
- By:
- Publication type:
- Article
Correction: CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 3, p. 587, doi. 10.1111/vco.12812
- By:
- Publication type:
- Article
In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD‐0332991) for treating canine mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 4, p. 507, doi. 10.1111/vco.12514
- By:
- Publication type:
- Article
Investigation of the cytotoxic effect of flavopiridol in canine lymphoma cell lines.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, p. 95, doi. 10.1111/vco.12130
- By:
- Publication type:
- Article
Ion Mobility Mass Spectrometry Measures the Conformational Landscape of p27 and its Domains and how this is Modulated upon Interaction with Cdk2/cyclin A.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 10, p. 3146, doi. 10.1002/ange.201812697
- By:
- Publication type:
- Article
Novel Karyotypes and Cydin D1 Immunoreactivity in Clear Cell Sarcoma of the Kidney.
- Published in:
- Pediatric & Developmental Pathology, 2015, v. 18, n. 4, p. 297, doi. 10.2350/14-12-1581-OA.1
- By:
- Publication type:
- Article
Identification of peripheral blood test parameters predicting the response to palbociclib and endocrine therapy for metastatic breast cancer: a retrospective study in a single institution.
- Published in:
- Surgery Today, 2025, v. 55, n. 2, p. 188, doi. 10.1007/s00595-024-02893-z
- By:
- Publication type:
- Article
High trefoil factor 1 (TFF1) expression in human retinoblastoma cells correlates with low growth kinetics, increased cyclin-dependent kinase (CDK) inhibitor levels and a selective down-regulation of CDK6.
- Published in:
- Histochemistry & Cell Biology, 2013, v. 139, n. 2, p. 323, doi. 10.1007/s00418-012-1028-y
- By:
- Publication type:
- Article
Exploration of the potential common pathogenic mechanisms in COVID-19 and silicosis by using bioinformatics and system biology.
- Published in:
- Functional & Integrative Genomics, 2023, v. 23, n. 3, p. 1, doi. 10.1007/s10142-023-01092-2
- By:
- Publication type:
- Article
Molecular Docking and 3D QSAR Research of Indolocarbazole Series as Cyclin-Dependent Kinase Inhibitors.
- Published in:
- Journal of Structural Chemistry, 2018, v. 59, n. 7, p. 1555, doi. 10.1134/S0022476618070065
- By:
- Publication type:
- Article
Palbociclib negatively regulates fatty acid synthesis due to upregulation of AMPKα and miR-33a levels to increase apoptosis in Panc-1 and MiaPaCa-2 cells.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 1, p. 342, doi. 10.1002/bab.2113
- By:
- Publication type:
- Article
Distinct outcomes from targeted perturbations of the multi-subunit SCF<sup>Skp2</sup> E3 ubiquitin ligase in blocking Trp53/Rb1-null prostate tumorigenesis.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07662-3
- By:
- Publication type:
- Article
Cyclin-dependent kinase inhibitor 1 plays a more prominent role than activating transcription factor 4 or the p53 tumour suppressor in thapsigargin-induced G1 arrest.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16683
- By:
- Publication type:
- Article
Long non-coding RNA L13Rik promotes high glucose-induced mesangial cell hypertrophy and matrix protein expression by regulating miR-2861/CDKN1B axis.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16170
- By:
- Publication type:
- Article
Prognostic values of GMPS, PR, CD40, and p21 in ovarian cancer.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.6301
- By:
- Publication type:
- Article
Untitled.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 8, doi. 10.1093/jnci/djv233
- Publication type:
- Article
Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 21, p. 1673, doi. 10.1093/jnci/djs373
- By:
- Publication type:
- Article
Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 693, doi. 10.1080/14756366.2021.1890726
- By:
- Publication type:
- Article
Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow stem cells.
- Published in:
- Cell Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41421-022-00505-z
- By:
- Publication type:
- Article
Inactivition of CDKL3 mildly inhibits proliferation of cells at VZ/SVZ in brain.
- Published in:
- Neurological Sciences, 2015, v. 36, n. 2, p. 297, doi. 10.1007/s10072-014-1952-9
- By:
- Publication type:
- Article
Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl- d-aspartate receptor subunit 2A.
- Published in:
- Neurological Sciences, 2014, v. 35, n. 9, p. 1365, doi. 10.1007/s10072-014-1713-9
- By:
- Publication type:
- Article
Dynamic changes of PIRH2 and p27kip1 expression in injured rat sciatic nerve.
- Published in:
- Neurological Sciences, 2012, v. 33, n. 4, p. 749, doi. 10.1007/s10072-011-0809-8
- By:
- Publication type:
- Article
Ribociclib and palbociclib-induced erythema multiforme: a case report.
- Published in:
- Oxford Medical Case Reports, 2022, v. 2022, n. 11, p. 1, doi. 10.1093/omcr/omac116
- By:
- Publication type:
- Article
Angiotensin II signalling kicks out p27<sup>Kip1</sup>: casein kinase 2 augmentation of Ca<sub>v</sub>1.2 L-type Ca<sup>2+</sup> channel activity in immature ventricular cardiomyocytes.
- Published in:
- Journal of Physiology, 2017, v. 595, n. 13, p. 4131, doi. 10.1113/JP274260
- By:
- Publication type:
- Article
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma.
- Published in:
- Scientific Reports, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41598-025-85364-w
- By:
- Publication type:
- Article
Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR<sup>+</sup>/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-82137-9
- By:
- Publication type:
- Article
The deleterious effects of CDK4/6 inhibition on renal recovery post-acute kidney injury.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-79663-x
- By:
- Publication type:
- Article
The novel selective inhibitors of cyclin-dependent kinase 4/6: in vitro and in silico study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-71865-7
- By:
- Publication type:
- Article
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67126-2
- By:
- Publication type:
- Article
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67126-2
- By:
- Publication type:
- Article
Deriving general structure–activity/selectivity relationship patterns for different subfamilies of cyclin-dependent kinase inhibitors using machine learning methods.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66173-z
- By:
- Publication type:
- Article
Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61271-4
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase Inhibitor 2A/B Homozygous Deletion Prediction and Survival Analysis.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 4, p. 548, doi. 10.3390/brainsci13040548
- By:
- Publication type:
- Article
Immunohistochemical Expression of p27 Kip1 , p57 Kip2 , Cyclin D1, Nestin, and Ki-67 in Ependymoma.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 2, p. 282, doi. 10.3390/brainsci12020282
- By:
- Publication type:
- Article
An Overview of the Safety Profile and Clinical Impact of CDK4/6 Inhibitors in Breast Cancer—A Systematic Review of Randomized Phase II and III Clinical Trials.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1422, doi. 10.3390/biom13091422
- By:
- Publication type:
- Article
Pancreatic Cancer Research beyond DNA Mutations.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 10, p. N.PAG, doi. 10.3390/biom12101503
- By:
- Publication type:
- Article
Marine-Derived Biomolecules.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1447, doi. 10.3390/biom10101447
- By:
- Publication type:
- Article
The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 8, p. 1199, doi. 10.3390/biom10081199
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 2, p. 275, doi. 10.3390/biom10020275
- By:
- Publication type:
- Article
EP18.35: Association of CDKN2A/2B genes single nucleotide polymorphisms with gestational diabetes mellitus.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2024, v. 64, p. 291, doi. 10.1002/uog.28771
- By:
- Publication type:
- Article
Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00055
- By:
- Publication type:
- Article
Treatment effect of CDKN1A on rheumatoid arthritis by mediating proliferation and invasion of fibroblast‐like synoviocytes cells.
- Published in:
- Clinical & Experimental Immunology, 2018, v. 194, n. 2, p. 220, doi. 10.1111/cei.13161
- By:
- Publication type:
- Article
Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1379, doi. 10.1038/bmt.2015.143
- By:
- Publication type:
- Article